Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
Merck
AstraZeneca
Moodys
Boehringer Ingelheim
Baxter

Last Updated: December 14, 2019

DrugPatentWatch Database Preview

ATENOLOL; CHLORTHALIDONE - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for atenolol; chlorthalidone and what is the scope of patent protection?

Atenolol; chlorthalidone is the generic ingredient in three branded drugs marketed by Alvogen, Mylan, Nostrum Labs, Pliva, Sun Pharm Industries, Watson Labs, and Zydus Pharms, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-four drug master file entries for atenolol; chlorthalidone. Eleven suppliers are listed for this compound.

Recent Clinical Trials for ATENOLOL; CHLORTHALIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Agenzia Italiana del FarmacoPhase 4
Federico II UniversityPhase 4
VA Office of Research and DevelopmentN/A

See all ATENOLOL; CHLORTHALIDONE clinical trials

Pharmacology for ATENOLOL; CHLORTHALIDONE
Paragraph IV (Patent) Challenges for ATENOLOL; CHLORTHALIDONE
Tradename Dosage Ingredient NDA Submissiondate
TENORETIC 100 TABLET;ORAL atenolol; chlorthalidone 018760
TENORETIC 50 TABLET;ORAL atenolol; chlorthalidone 018760

US Patents and Regulatory Information for ATENOLOL; CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073665-002 Jul 2, 1992 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 210028-001 Mar 8, 2019 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074203-001 Oct 31, 1993 AB RX No No   Start Trial   Start Trial   Start Trial
Mylan ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074203-002 Oct 31, 1993 AB RX No No   Start Trial   Start Trial   Start Trial
Pliva ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 074107-002 Sep 24, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ATENOLOL; CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Alvogen TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984   Start Trial   Start Trial
Alvogen TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984   Start Trial   Start Trial
Alvogen TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984   Start Trial   Start Trial
Alvogen TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984   Start Trial   Start Trial
Alvogen TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Dow
Harvard Business School
Moodys
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.